Loading
Latest filing published 07 Nov 2017 for Spero Therapeutics, Inc..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Casper Breum is a declared insider of Spero Therapeutics, Inc., with filings sourced from SEC (Form 4). Altogether 4 filings, all relating to 6 November 2017.
On the market, this insider has only ever bought: 1 purchase, €2.6M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 7 November 2017, the filings show a transaction in Spero Therapeutics, Inc. The last purchase on record was published on 7 November 2017, which is 3,272 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations